TMB-365

N/A

Report date: 2025/04/28 22:35:30

Base Information

Drug NameTMB-365
Drug Alias NameTMB-365
ClassificationBiologics
Mechanisms of ActionAnti-CD4Viral fusion proteins inhibitors
TargetsT-cell surface antigen CD4Viral fusion proteins
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaimed Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaimed Biologics Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A